ArticleFrontiers in oncology2025
Identifying small thymomas from other asymptomatic anterior mediastinal nodules based on CT images using logistic regression.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To develop and validate a logistic regression (LR) model to improve the diagnostic performance of chest CT in distinguishing small (≤3 cm in long diameter on CT) thymomas from other asymptomatic small anterior mediastinal nodules (SAMNs). Materials and methods: A total of 231 patients (94 thymomas and 137 other SAMNs) with surgically resected asymptomatic SAMNs underwenting plain CT and biphasic enhanced CT from January 2013 to December 2023 were included and randomly allocated into training and internal testing sets at a 7:3 ratio. Clinical and CT features were analyzed, and a predictive model was developed based on independent risk features for small thymomas using multivariate LR in the training set. Receiver operating characteristic (ROC) curves and decision curve analysis (DCA) were used to compare the performance of the model and individual risk factors in the internal testing set. An additional prospective testing set (10 thymomas and 13 other SAMNs) was collected from the same institution between 2023 and 2024. The model's performance was evaluated by area under the curve (AUC) and compared with the results of three radiologists using the DeLong test. Results: The LR model incorporating four CT independent risk features (lesion location, attenuation pattern, CT values in the venous phase [CTV], and enhancement degree) achieved an AUC of 0.887 for small thymomas prediction. This performance was superior to CTV alone (AUC = 0.849, P = 0.118) and significantly higher than other individual risk factors in the internal testing set (P < 0.05). DCA confirmed the model's enhanced clinical utility across most threshold probabilities. In the prospective test set, the LR showed an AUC of 0.908 (95% CI: 0.765-1.00), comparable to the senior radiologist's performance (AUC = 0.912 [95% CI: 0.765-1.00], P = 0.961), higher than the intermediate radiologist's performance (AUC = 0.762 [95% CI: 0.554-0.969], P = 0.094), and significantly better than the junior radiologist's performance (AUC = 0.700 [95% CI: 0.463-0.937], P = 0.044). Conclusions: The CT-based LR model demonstrated well diagnostic performance comparable to that of senior radiologists in differentiating small thymomas from other asymptomatic SAMNs. CTV played a leading role in the model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.